Delamanid

Delamanid is an antimycobacterial compound. It is active against clinical isolates of M. tuberculosis that are susceptible (MIC90s = 0.01194-0.01248 µg/ml) or resistant to rifampicin (Cay-14423), isoniazid (Cay-20378), ethambutol (Cay-23713), and/or streptomycin (Cay-21211, MIC90s = 0.01221-0.01341 µg/ml). It inhibits the synthesis of methoxy- and keto-mycolic acid in the M. bovis strain BCG (IC50s = 0.036 and 0.021 µg/ml, respectively). Delamanid (0.1, 0.3, and 1 µg/ml) inhibits the growth of the M. tuberculosis strain H37Rv in infected THP-1 cells. It decreases lung bacterial burden in a mouse model of M. tuberculosis infection in a dose-dependent manner.Formal Name: (2R)-2,3-dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]-imidazo[2,1-b]oxazole. CAS Number: 681492-22-8. Synonyms: OPC-67683. Molecular Formula: C25H25F3N4O6. Formula Weight: 534.5. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 25 mg/ml, DMSO: 20 mg/ml, Ethanol: partially soluble. lambdamax: 220, 244, 316 nm. SMILES: FC(F)(F)OC(C=C1)=CC=C1OC2CCN(C3=CC=C(OC[C@]4(C)OC5=NC([N+]([O-])=O)=CN5C4)C=C3)CC2. InChi Code: InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1. InChi Key: XDAOLTSRNUSPPH-XMMPIXPASA-N.